Areas of activity

from basic research to new therapies development

Rare Partners is focusing in the field of translational research and product development, with the final goal of developing new drugs and diagnostics for rare pathologies.

As regards therapeutic agents, both approaches commonly applied to drug development, i.e. “small molecules” as well as “biologicals”, are taken into consideration.

An important activity of project scouting has been undertaken, in order to identifying the most interesting projects, which have in common the need for exploratory development activities, which represent the main area of activity of Rare Partners.

Specific Tasks

Once an interesting project is identified and an agreement with the research institution originator of the innovative product or diagnostic tool is reached, Rare Partners takes the responsibility of performing all activities required for the project development, including management of:

  • Project planning and administration
  • Activities outsourced to third parties
  • Product development
  • Intellectual property and legal issues
  • Regulatory issues, including Orphan Drug Designation application
  • Quality Compliance issues, including those concerning the clinical trials
  • Fund raising
  • Grant applications directed to regional, national and international calls
  • Dissemination of the results
  • Contacts with industrial partners potentially interested in the exploitation of the results
  • Identification of the best partner for further development
  • Collaboration with the industrial partner(s).